Secondary prevention of ischaemic cardiac events.
Sudlow
Cathie
C
Department of Neurosciences, University of Edinburgh, Edinbugrh, UK.
Lonn
Eva
E
Pignone
Michael
M
Ness
Andrew
A
Rihal
Charanjit
C
D015906:Angioplasty, Balloon, Coronary; D002317:Cardiovascular Agents / Q000009:adverse effects / Q000627:therapeutic use; D001026:Coronary Artery Bypass; D004148:Dioxolanes; D005247:Feeding Behavior; D006538:Heptanoic Acids; D006801:Humans; D008019:Life Style; D009203:Myocardial Infarction / Q000209:etiology / Q000401:mortality / Q000517:prevention & control* / Q000628:therapy; D017202:Myocardial Ischemia / Q000209:etiology / Q000401:mortality / Q000517:prevention & control* / Q000628:therapy; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012307:Risk Factors; D015607:Stents; D015996:Survival Rate; D016896:Treatment Outcome
D002317:Cardiovascular Agents; D004148:Dioxolanes; D006538:Heptanoic Acids; C056803:Sch 31828